insights_auto
Why is PRQR up 3.82%?
Dive Deeperchevron_right
PRQR:NASDAQ
ProQR Therapeutics NV
$1.63
arrow_upward
+3.82%(+0.060) 1D
$1.60
arrow_downward
-1.84% (-0.030)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.57
High
$1.63
Low
$1.56
Mkt. cap
230.03M
Avg. vol.
678.91K
Volume
676.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
Open
$1.57
High
$1.63
Low
$1.56
Mkt. cap
230.03M
Avg. vol.
678.91K
Volume
676.09K
52-wk high
$3.10
52-wk low
$1.34
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
Stock Titan
·
6 minutes ago
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
Foreign Policy Journal
·
32 minutes ago
Lululemon (NASDAQ: LULU) Faces Brand Reckoning As Sales Slump And Hedge Funds Retreat
Stock Titan
·
5 minutes ago
In fiscal 2026, customers bought 466 vehicle energy storage systems from Scage.
Barchart.com
·
3 hours ago
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV